Trial Profile
A Randomized, Intra-individual, Prospective Study Comparing Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Ablative Fractional Laser Treatment in Asian Patients With Lower Extremity Bowen's Disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Aug 2013
Price :
$35
*
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Bowen's disease
- Focus Therapeutic Use
- 11 Aug 2013 New trial record